We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alkemy Capital Investments Plc | LSE:ALK | London | Ordinary Share | GB00BMD6C023 | ORD GBP0.02 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 87.50 | 85.00 | 90.00 | 90.00 | 87.50 | 90.00 | 2,726 | 08:00:43 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 0 | -2.65M | -0.3239 | -2.70 | 7.14M |
From May 2022 to May 2024
TIDMALK TIDMB
On Thursday, 11 August 2022, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its six-month interim report (Q2) 2022.
ALK will host a meeting for analysts and institutional investors that day at 1.30 pm (CEST) at which Management will review the financial results, the outlook and answer questions.
The meeting will be audio cast live on our website https://ir.alk.net, where the related presentation will be available shortly before the meeting begins.
Participants in the conference call are kindly requested to call in before 1.25 pm (CEST). Danish participants should call in on tel. +45 7877 4197 and international participants should call in on tel. +44 808 101 1183 or +1 785 424 1226. Please use the following participant pin code: 35630#
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, mobile +45 3050 2014
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,600 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
Attachment
Hot Features
Premium
-- InvestorNews_04Aug22
https://ml-eu.globenewswire.com/Resource/Download/4454c6d3-3820-4b13-8176-03dde9de33e0
(END) Dow Jones Newswires
August 04, 2022 09:32 ET (13:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Alkemy Capital Investments Chart |
1 Month Alkemy Capital Investments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
